Cargando…
Renal denervation – can we press the “ON” button again?
Nearly ten years ago percutaneous renal denervation (RDN) was introduced in clinical trials as a possible method of interventional treatment of resistant hypertension. The promising results of the first clinical trials initiated the intensive development of this method. However, the role of percutan...
Autores principales: | Kądziela, Jacek, Warchoł-Celińska, Ewa, Prejbisz, Aleksander, Januszewicz, Andrzej, Witkowski, Adam, Tsioufis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309838/ https://www.ncbi.nlm.nih.gov/pubmed/30603021 http://dx.doi.org/10.5114/aic.2018.79863 |
Ejemplares similares
-
Renal denervation: can we press the “ON” button again in 2020?
por: Kądziela, Jacek, et al.
Publicado: (2020) -
Renal denervation – current evidence and perspectives
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2013) -
Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014) -
Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease
por: Prejbisz, Aleksander, et al.
Publicado: (2013) -
Renal denervation – where do we stand in 2014?
por: Januszewicz, Andrzej, et al.
Publicado: (2014)